Personalising haemophilia management with shared decision making

1 Barry MJ, Edgman-Levitan S. Shared decision making--pinnacle of patient-centered care. N Engl J Med 2012; 366(9): 780–1. doi: 10.1056/NEJMp1109283. BarryMJ Edgman-LevitanS Shared decision making--pinnacle of patient-centered care N Engl J Med 2012 366 9 780 1 10.1056/NEJMp1109283 22375967 Open DOISearch in Google Scholar

2 Karazivan P, Dumez V, Flora L, et al. The patient-as-partner approach in health care: a conceptual framework for a necessary transition. Acad Med 2015; 90(4): 437–41. doi: 10.1097/ACM.0000000000000603. KarazivanP DumezV FloraL The patient-as-partner approach in health care: a conceptual framework for a necessary transition Acad Med 2015 90 4 437 41 10.1097/ACM.0000000000000603 25607943 Open DOISearch in Google Scholar

3 Nossair F, Thornburg CD. The role of patient and healthcare professionals in the era of new hemophilia treatments in developed and developing countries. Ther Adv Hematol 2018; 9(8): 239–249. doi: 10.1177/2040620718784830. NossairF ThornburgCD The role of patient and healthcare professionals in the era of new hemophilia treatments in developed and developing countries Ther Adv Hematol 2018 9 8 239 249 10.1177/2040620718784830 611675730181844 Open DOISearch in Google Scholar

4 Fillion E. How is medical decision-making shared? The case of haemophilia patients and doctors: the aftermath of the infected blood affair in France. Health Expect 2003; 6(3): 228–41. doi: 10.1046/j.1369-6513.2003.00244.x. FillionE How is medical decision-making shared? The case of haemophilia patients and doctors: the aftermath of the infected blood affair in France Health Expect 2003 6 3 228 41 10.1046/j.1369-6513.2003.00244.x 506018112940796 Open DOISearch in Google Scholar

5 Berger Z. Navigating the unknown: shared decision-making in the face of uncertainty. J Gen Intern Med 2015; 30(5): 675–8. doi: 10.1007/s11606-014-3074-8. BergerZ Navigating the unknown: shared decision-making in the face of uncertainty J Gen Intern Med 2015 30 5 675 8 10.1007/s11606-014-3074-8 439558925536912 Open DOISearch in Google Scholar

6 Montori VM, Gafni A, Charles C. A shared treatment decision-making approach between patients with chronic conditions and their clinicians: the case of diabetes. Health Expect 2006; 9(1): 25–36. doi: 10.1111/j.1369-7625.2006.00359.x. MontoriVM GafniA CharlesC A shared treatment decision-making approach between patients with chronic conditions and their clinicians: the case of diabetes Health Expect 2006 9 1 25 36 10.1111/j.1369-7625.2006.00359.x 506032316436159 Open DOISearch in Google Scholar

7 Elwyn G, Frosch D, Thomson R, et al. Shared decision making: a model for clinical practice. J Gen Intern Med 2012; 27(10): 1361–7. doi: 10.1007/s11606-012-2077-6. ElwynG FroschD ThomsonR Shared decision making: a model for clinical practice J Gen Intern Med 2012 27 10 1361 7 10.1007/s11606-012-2077-6 344567622618581 Open DOISearch in Google Scholar

8 Hauser K, Koerfer A, Kuhr K, Albus C, Herzig S, Matthes J. Outcome-relevant effects of shared decision making. Dtsch Arztebl Int 2015; 112(40): 665–71. doi: 10.3238/arztebl.2015.0665. HauserK KoerferA KuhrK AlbusC HerzigS MatthesJ Outcome-relevant effects of shared decision making Dtsch Arztebl Int 2015 112 40 665 71 10.3238/arztebl.2015.0665 464007026517594 Open DOISearch in Google Scholar

9 Matlock DD, Spatz ES. Design and testing of tools for shared decision making. Circ Cardiovasc Qual Outcomes 2014; 7(3): 487–92. doi: 10.1161/CIRCOUTCOMES.113.000289. MatlockDD SpatzES Design and testing of tools for shared decision making Circ Cardiovasc Qual Outcomes 2014 7 3 487 92 10.1161/CIRCOUTCOMES.113.000289 24714602 Open DOISearch in Google Scholar

10 Drug and Therapeutics Bulletin. An introduction to patient decision aids. BMJ 2013; 347: f4147. doi: 10.1136/bmj.f4147. Drug and Therapeutics Bulletin An introduction to patient decision aids BMJ 2013 347 f4147 10.1136/bmj.f4147 23881944 Open DOISearch in Google Scholar

11 Agency for Healthcare Research and Quality. The SHARE Approach. Available from https://www.ahrq.gov/professionals/education/curriculum-tools/shareddecisionmaking/index.html (accessed 28 March 2019). Agency for Healthcare Research and Quality The SHARE Approach Available from https://www.ahrq.gov/professionals/education/curriculum-tools/shareddecisionmaking/index.html (accessed 28 March 2019). Search in Google Scholar

12 Lamiani G, Bigi S, Mancuso ME, Coppola A, Vegni E. Applying a deliberation model to the analysis of consultations in haemophilia: Implications for doctor-patient communication. Patient Educ Couns 2017; 100(4): 690–695. doi: 10.1016/j.pec.2016.11.021. LamianiG BigiS MancusoME CoppolaA VegniE Applying a deliberation model to the analysis of consultations in haemophilia: Implications for doctor-patient communication Patient Educ Couns 2017 100 4 690 695 10.1016/j.pec.2016.11.021 Open DOISearch in Google Scholar

13 Dolan JG. Shared decision-making--transferring research into practice: the Analytic Hierarchy Process (AHP). Patient Educ Couns 2008; 73(3): 418–25. doi: 10.1016/j.pec.2008.07.032. DolanJG Shared decision-making--transferring research into practice: the Analytic Hierarchy Process (AHP) Patient Educ Couns 2008 73 3 418 25 10.1016/j.pec.2008.07.032 Open DOISearch in Google Scholar

14 Shay LA, Lafata JE. Where is the evidence? A systematic review of shared decision making and patient outcomes. Med Decis Making 2015; 35(1): 114–31. doi: 10.1177/0272989X14551638. ShayLA LafataJE Where is the evidence? A systematic review of shared decision making and patient outcomes Med Decis Making 2015 35 1 114 31 10.1177/0272989X14551638 Open DOISearch in Google Scholar

15 Beers E, Nilsen ML, Johnson JT. The role of patients: shared decision-making. Otolaryngol Clin North Am 2017; 50(4): 689–708. doi: 10.1016/j.otc.2017.03.006. BeersE NilsenML JohnsonJT The role of patients: shared decision-making Otolaryngol Clin North Am 2017 50 4 689 708 10.1016/j.otc.2017.03.006 Open DOISearch in Google Scholar

16 Del Río-Lanza AB, Suárez-Álvarez L, Suárez-Vázquez A, Vázquez-Casielles R. Information provision and attentive listening as determinants of patient perceptions of shared decision-making around chronic illnesses. Springerplus 2016; 5(1): 1386. doi: 10.1186/s40064-016-3086-4. Del Río-LanzaAB Suárez-ÁlvarezL Suárez-VázquezA Vázquez-CasiellesR Information provision and attentive listening as determinants of patient perceptions of shared decision-making around chronic illnesses Springerplus 2016 5 1 1386 10.1186/s40064-016-3086-4 Open DOISearch in Google Scholar

17 Joseph-Williams N, Lloyd A, Edwards A, et al. Implementing shared decision making in the NHS: lessons from the MAGIC programme. BMJ 2017; 357: j1744. doi: 10.1136/bmj.j1744. Joseph-WilliamsN LloydA EdwardsA Implementing shared decision making in the NHS: lessons from the MAGIC programme BMJ 2017 357 j1744 10.1136/bmj.j1744 Open DOISearch in Google Scholar

18 Epstein RM. Whole mind and shared mind in clinical decision-making. Patient Educ Couns 2013; 90(2): 200–6. doi: 10.1016/j.pec.2012.06.035. EpsteinRM Whole mind and shared mind in clinical decision-making Patient Educ Couns 2013 90 2 200 6 10.1016/j.pec.2012.06.035 Open DOISearch in Google Scholar

19 Frosch DL, Kaplan RM. Shared decision making in clinical medicine: past research and future directions. Am J Prev Med 1999; 17(4): 285–94. doi: 10.1016/s0749-3797(99)00097-5. FroschDL KaplanRM Shared decision making in clinical medicine: past research and future directions Am J Prev Med 1999 17 4 285 94 10.1016/s0749-3797(99)00097-5 Open DOISearch in Google Scholar

20 Elwyn G, Frosch DL, Kobrin S. Implementing shared decision-making: consider all the consequences. Implementation Sci 2015; 11: 114. doi: 10.1186/s13012-016-0480-9. ElwynG FroschDL KobrinS Implementing shared decision-making: consider all the consequences Implementation Sci 2015 11 114 10.1186/s13012-016-0480-9 497765027502770 Open DOISearch in Google Scholar

21 Barratt A. Evidence based medicine and shared decision making: the challenge of getting both evidence and preferences into health care. Patient Educ Couns 2008; 73(3): 407–12. doi: 10.1016/j.pec.2008.07.054. BarrattA Evidence based medicine and shared decision making: the challenge of getting both evidence and preferences into health care Patient Educ Couns 2008 73 3 407 12 10.1016/j.pec.2008.07.054 18845414 Open DOISearch in Google Scholar

22 National Hemophilia Foundation. MASAC Document #241 – Recommendation concerning prophylaxis. February 28, 2016. Available from http://www.hemophilia.org/NHFWeb/MainPgs/MainNHF.aspx?menuid=57&contentid=1007 (accessed 23 June 2016). National Hemophilia Foundation MASAC Document #241 – Recommendation concerning prophylaxis February 28, 2016. Available from http://www.hemophilia.org/NHFWeb/MainPgs/MainNHF.aspx?menuid=57&contentid=1007 (accessed 23 June 2016). Search in Google Scholar

23 Srivastava A, Brewer AK, Mauser-Bunschoten EP, et al.; Treatment Guidelines Working Group on Behalf of the World Federation of Hemophilia. Guidelines for the management of hemophilia. Haemophilia 2013; 19(1): e1–e47. doi: 10.1111/j.1365-2516.2012.02909.x. SrivastavaA BrewerAK Mauser-BunschotenEP Treatment Guidelines Working Group on Behalf of the World Federation of Hemophilia Guidelines for the management of hemophilia Haemophilia 2013 19 1 e1 e47 10.1111/j.1365-2516.2012.02909.x 22776238 Open DOISearch in Google Scholar

24 Collins PW. Personalized prophylaxis. Haemophilia 2012; 18(Suppl 4): 131–5. doi: 10.1111/j.1365-2516.2012.02838.x. CollinsPW Personalized prophylaxis Haemophilia 2012 18 Suppl 4 131 5 10.1111/j.1365-2516.2012.02838.x 22726096 Open DOISearch in Google Scholar

25 Valentino LA. Considerations in individualizing prophylaxis in patients with haemophilia A. Haemophilia 2014; 20(5): 607–15. doi: 10.1111/hae.12438. ValentinoLA Considerations in individualizing prophylaxis in patients with haemophilia A Haemophilia 2014 20 5 607 15 10.1111/hae.12438 24712891 Open DOISearch in Google Scholar

26 Simhadri VL, Banerjee AS, Simon J, Kimchi-Sarfaty C, Sauna ZE. Personalized approaches to the treatment of hemophilia A and B. Per Med 2015; 12(4): 403–415. doi: 10.2217/pme.15.6. SimhadriVL BanerjeeAS SimonJ Kimchi-SarfatyC SaunaZE Personalized approaches to the treatment of hemophilia A and B Per Med 2015 12 4 403 415 10.2217/pme.15.6 29771661 Open DOISearch in Google Scholar

27 Valentino LA, Mamonov V, Hellmann A, et al. A randomized comparison of two prophylaxis regimens and a paired comparison of on-demand and prophylaxis treatments in hemophilia A management. J Thromb Haemost 2012; 10(3): 359–67. doi: 10.1111/j.1538-7836.2011.04611.x. ValentinoLA MamonovV HellmannA A randomized comparison of two prophylaxis regimens and a paired comparison of on-demand and prophylaxis treatments in hemophilia A management J Thromb Haemost 2012 10 3 359 67 10.1111/j.1538-7836.2011.04611.x 348830122212248 Open DOISearch in Google Scholar

28 Mahlangu J, Powell JS, Ragni MV, et al. Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A. Blood 2014; 123(3): 317–25. doi: 10.1182/blood-2013-10-529974. MahlanguJ PowellJS RagniMV Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A Blood 2014 123 3 317 25 10.1182/blood-2013-10-529974 389449124227821 Open DOISearch in Google Scholar

29 Perrin GQ, Herzog RW, Markusic DM. Update on clinical gene therapy for hemophilia. Blood 2019; 133(5): 407–14. doi: 10.1182/blood-2018-07-820720. PerrinGQ HerzogRW MarkusicDM Update on clinical gene therapy for hemophilia Blood 2019 133 5 407 14 10.1182/blood-2018-07-820720 635698530559260 Open DOISearch in Google Scholar

30 Rodriguez-Merchan EC, Valentino LA. Emicizumab: Review of the literature and critical appraisal. Haemophilia 2019; 25(1): 11–20. doi: 10.1111/hae.13641. Rodriguez-MerchanEC ValentinoLA Emicizumab: Review of the literature and critical appraisal Haemophilia 2019 25 1 11 20 10.1111/hae.13641 30431213 Open DOISearch in Google Scholar

31 Hacker MR, Geraghty S, Manco-Johnson M. Barriers to compliance with prophylaxis therapy in haemophilia. Haemophilia 2001; 7(4): 392–6. doi: 10.1046/j.1365-2516.2001.00534.x. HackerMR GeraghtyS Manco-JohnsonM Barriers to compliance with prophylaxis therapy in haemophilia Haemophilia 2001 7 4 392 6 10.1046/j.1365-2516.2001.00534.x 11442644 Open DOISearch in Google Scholar

32 De Moerloose P, Urbancik W, Van Den Berg HM, Richards M.A survey of adherence to haemophilia therapy in six European countries: results and recommendations. Haemophilia 2008; 14(5): 931–8. doi: 10.1111/j.1365-2516.2008.01843.x. De MoerlooseP UrbancikW Van Den BergHM RichardsM A survey of adherence to haemophilia therapy in six European countries: results and recommendations Haemophilia 2008 14 5 931 8 10.1111/j.1365-2516.2008.01843.x 18684125 Open DOISearch in Google Scholar

33 Du Treil S, Rice J, Leissinger CA. Quantifying adherence to treatment and its relationship to quality of life in a well-characterized haemophilia population. Haemophilia 2007; 13(5): 493–501. doi: 10.1111/j.1365-2516.2007.01526.x. Du TreilS RiceJ LeissingerCA Quantifying adherence to treatment and its relationship to quality of life in a well-characterized haemophilia population Haemophilia 2007 13 5 493 501 10.1111/j.1365-2516.2007.01526.x 17880435 Open DOISearch in Google Scholar

34 Thornburg CD, Carpenter S, Zappa S, Munn J, Leissinger C. Current prescription of prophylactic factor infusions and perceived adherence for children and adolescents with haemophilia: a survey of haemophilia healthcare professionals in the United States. Haemophilia 2012; 18(4): 568–74. doi: 10.1111/j.1365-2516.2012.02756.x. ThornburgCD CarpenterS ZappaS MunnJ LeissingerC Current prescription of prophylactic factor infusions and perceived adherence for children and adolescents with haemophilia: a survey of haemophilia healthcare professionals in the United States Haemophilia 2012 18 4 568 74 10.1111/j.1365-2516.2012.02756.x 22335526 Open DOISearch in Google Scholar

35 Machin N, Ragni MV, Smith KJ. Gene therapy in hemophilia A: a cost-effectiveness analysis. Blood Adv 2018; 2(14): 1792–1798. doi: 10.1182/bloodadvances.2018021345. MachinN RagniMV SmithKJ Gene therapy in hemophilia A: a cost-effectiveness analysis Blood Adv 2018 2 14 1792 1798 10.1182/bloodadvances.2018021345 605823630042145 Open DOISearch in Google Scholar

36 Manco-Johnson MJ, Abshire TC, Shapiro AD, et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med 2007; 357(6): 535–44. doi: 10.1056/NEJMoa067659. Manco-JohnsonMJ AbshireTC ShapiroAD Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia N Engl J Med 2007 357 6 535 44 10.1056/NEJMoa067659 17687129 Open DOISearch in Google Scholar

37 Ellis AG, Mickle K, Herron-Smith S, et al. Spinraza^® and Zolgensma^® for spinal muscular atrophy: effectiveness and value. Final evidence report. Institue for Clinical and Economic Review, April 3, 2019. Available from https://34eyj51jerf417itp82ufdoe-wpengine.netdna-ssl.com/wp-content/uploads/2020/10/ICER_SMA_Final_Evidence_Report_110220.pdf (accessed 28 April 2021). EllisAG MickleK Herron-SmithS Spinraza^® and Zolgensma^® for spinal muscular atrophy: effectiveness and value. Final evidence report Institue for Clinical and Economic Review April 3 2019 Available from https://34eyj51jerf417itp82ufdoe-wpengine.netdna-ssl.com/wp-content/uploads/2020/10/ICER_SMA_Final_Evidence_Report_110220.pdf (accessed 28 April 2021). Search in Google Scholar

38 Pierce GF. Uncertainty in an era of transformative therapy for haemophilia: Addressing the unknowns. Haemophilia 2020; 27 (S3): 103–13. doi: 10.1111/hae.14023. PierceGF Uncertainty in an era of transformative therapy for haemophilia: Addressing the unknowns Haemophilia 2020 27 S3 103 13 10.1111/hae.14023 32484283 Open DOISearch in Google Scholar

39 Pierce GF, Pasi KJ, Coffin D, et al.; Members of the WFH Gene Therapy Round Table Program Organizing Committee. Towards a global multidisciplinary consensus framework on haemophilia gene therapy: Report of the 2nd World Federation of Haemophilia Gene Therapy Round Table. Haemophilia 2020; 26(3): 443–449. doi: 10.1111/hae.13971. PierceGF PasiKJ CoffinD Members of the WFH Gene Therapy Round Table Program Organizing Committee Towards a global multidisciplinary consensus framework on haemophilia gene therapy: Report of the 2nd World Federation of Haemophilia Gene Therapy Round Table Haemophilia 2020 26 3 443 449 10.1111/hae.13971 32202382 Open DOISearch in Google Scholar

40 US Food & Drug Administration. FDA approves emicizumabkxwh for hemophilia A with or without factor VIII inhibitors. 14 December 2018. Available from https://www.fda.gov/drugs/drug-approvals-and-databases/fda-approves-emicizumabkxwh-hemophilia-or-without-factor-viii-inhibitors (accessed 23 October 2019). US Food & Drug Administration FDA approves emicizumabkxwh for hemophilia A with or without factor VIII inhibitors 14 December 2018. Available from https://www.fda.gov/drugs/drug-approvals-and-databases/fda-approves-emicizumabkxwh-hemophilia-or-without-factor-viii-inhibitors (accessed 23 October 2019). Search in Google Scholar

41 HEMLIBRA^®. HEMLIBRA^® (emicizumab-kxwh) injection, for subcutaneous use [package insert]. Genentech, Inc., South San Francisco, CA, October 2018. HEMLIBRA^® HEMLIBRA^® (emicizumab-kxwh) injection, for subcutaneous use [package insert] Genentech, Inc. South San Francisco, CA October 2018 Search in Google Scholar

42 Franchini M, Mannucci PM. Non-factor replacement therapy for haemophilia: a current update. Blood Transfus 2018; 16(5): 457–461. doi: 10.2450/2018.0272-17. FranchiniM MannucciPM Non-factor replacement therapy for haemophilia: a current update Blood Transfus 2018 16 5 457 461 10.2450/2018.0272-17 612523029517971 Open DOISearch in Google Scholar

43 High KA, Roncarolo MG. Gene therapy. N Engl J Med 2019; 381(5): 455–464. doi: 10.1056/NEJMra1706910. HighKA RoncaroloMG Gene therapy N Engl J Med 2019 381 5 455 464 10.1056/NEJMra1706910 31365802 Open DOISearch in Google Scholar

44 Patel U, Boucher M, de Leseleuc L, Visintini S. Voretigene neparvovec: An emerging gene therapy for the treatment of inherited blindness. 2018 Mar 1. In: CADTH Issues in Emerging Health Technologies, Ottawa (ON) 2016–; 169. PatelU BoucherM de LeseleucL VisintiniS Voretigene neparvovec: An emerging gene therapy for the treatment of inherited blindness 2018 Mar 1 In: CADTH Issues in Emerging Health Technologies Ottawa (ON) 2016 169 Search in Google Scholar

45 ZOLGENSMA^®, ZOLGENSMA^® (onasemnogene abeparvovecxioi) suspension for intravenous infusion [package insert]. AveXis, In., Bannockburn, IL, 2019. ZOLGENSMA^® ZOLGENSMA^® (onasemnogene abeparvovecxioi) suspension for intravenous infusion [package insert] AveXis, In. Bannockburn, IL 2019 Search in Google Scholar

46 Brimble MA, Reiss UM, Nathwani AC, Davidoff AM. New and improved AAVenues: current status of hemophilia B gene therapy. Expert Opin Biol Ther 2016; 16(1): 79–92. doi: 10.1517/14712598.2015.1106475. BrimbleMA ReissUM NathwaniAC DavidoffAM New and improved AAVenues: current status of hemophilia B gene therapy Expert Opin Biol Ther 2016 16 1 79 92 10.1517/14712598.2015.1106475 26524468 Open DOISearch in Google Scholar

47 High KA, Skinner MW. Cell phones and landlines: the impact of gene therapy on the cost and availability of treatment for hemophilia. Mol Ther 2011; 19(10): 1749–50. doi: 10.1038/mt.2011.203. HighKA SkinnerMW Cell phones and landlines: the impact of gene therapy on the cost and availability of treatment for hemophilia Mol Ther 2011 19 10 1749 50 10.1038/mt.2011.203 318875421964303 Open DOISearch in Google Scholar

48 Pipe SW. Gene therapy for hemophilia. Pediatr Blood Cancer 2018; 65(2). doi: 10.1002/pbc.26865. PipeSW Gene therapy for hemophilia Pediatr Blood Cancer 2018 65 2 10.1002/pbc.26865 29077262 Open DOISearch in Google Scholar

49 Iorio A, Skinner MW, Clearfield E, et al.; coreHEM panel. Core outcome set for gene therapy in haemophilia: Results of the coreHEM multistakeholder project. Haemophilia 2018; 24(4): e167–e172. doi: 10.1111/hae.13504. IorioA SkinnerMW ClearfieldE coreHEM panel Core outcome set for gene therapy in haemophilia: Results of the coreHEM multistakeholder project Haemophilia 2018 24 4 e167 e172 10.1111/hae.13504 29781145 Open DOISearch in Google Scholar

50 Sun HL, McIntosh KA, Squire SJ, et al. Patient powered prophylaxis: A 12-month study of individualized prophylaxis in adults with severe haemophilia A. Haemophilia 2017; 23(6): 877–883. doi: 10.1111/hae.13319. SunHL McIntoshKA SquireSJ Patient powered prophylaxis: A 12-month study of individualized prophylaxis in adults with severe haemophilia A Haemophilia 2017 23 6 877 883 10.1111/hae.13319 28851133 Open DOISearch in Google Scholar

51 Arruda VR, Doshi BS, Samelson-Jones BJ. Novel approaches to hemophilia therapy: successes and challenges. Blood 2017; 130(21): 2251–2256. doi: 10.1182/blood-2017-08-742312. ArrudaVR DoshiBS Samelson-JonesBJ Novel approaches to hemophilia therapy: successes and challenges Blood 2017 130 21 2251 2256 10.1182/blood-2017-08-742312 581373529018078 Open DOISearch in Google Scholar

52 Pierce GF, Iorio A. Past, present and future of haemophilia gene therapy: From vectors and transgenes to known and unknown outcomes. Haemophilia 2018; 24 Suppl 6: 60–67. doi: 10.1111/hae.13489. PierceGF IorioA Past, present and future of haemophilia gene therapy: From vectors and transgenes to known and unknown outcomes Haemophilia 2018 24 Suppl 6 60 67 10.1111/hae.13489 29878660 Open DOISearch in Google Scholar

53 American Society of Gene & Cell Therapy. Gene Therapy 101. Available from https://www.asgct.org/education/gene-therapy-101 (accessed 17 October 2019. American Society of Gene & Cell Therapy Gene Therapy 101 Available from https://www.asgct.org/education/gene-therapy-101 (accessed 17 October 2019. Search in Google Scholar

54 Klifto K, Klifto C, Slover J. Current concepts of shared decision making in orthopedic surgery. Curr Rev Musculoskelet Med 2017; 10(2): 253–257. doi: 10.1007/s12178-017-9409-4. KliftoK KliftoC SloverJ Current concepts of shared decision making in orthopedic surgery Curr Rev Musculoskelet Med 2017 10 2 253 257 10.1007/s12178-017-9409-4 543564028337730 Open DOISearch in Google Scholar

55 Nathwani AC, Davidoff AM, Tuddenham EGD. Gene therapy for hemophilia. Hematol Oncol Clin North Am 2017; 31(5): 853–868. doi: 10.1016/j.hoc.2017.06.011. NathwaniAC DavidoffAM TuddenhamEGD Gene therapy for hemophilia Hematol Oncol Clin North Am 2017 31 5 853 868 10.1016/j.hoc.2017.06.011 28895852 Open DOISearch in Google Scholar

56 Stoffman J, Andersson NG, Branchford B, et al. Common themes and challenges in hemophilia care: a multinational perspective. Hematology 2019; 24(1): 39–48. doi: 10.1080/10245332.2018.1505225. StoffmanJ AnderssonNG BranchfordB Common themes and challenges in hemophilia care: a multinational perspective Hematology 2019 24 1 39 48 10.1080/10245332.2018.1505225 30073913 Open DOISearch in Google Scholar